Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients
Open Access
- 13 June 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 27 (1), 202-207
- https://doi.org/10.1038/leu.2012.159
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Heavy/Light-Chain Analysis of Monoclonal GammopathiesClinical Chemistry, 2009
- International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersLeukemia, 2008
- Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging systemLeukemia, 2008
- Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalitiesClinical and Experimental Immunology, 2007
- Relationship Between Depth of Response and Outcome in Multiple MyelomaJournal of Clinical Oncology, 2007
- High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosisBlood, 2007
- Perspective – FcRn transports albumin: relevance to immunology and medicineTrends in Immunology, 2006
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Magnitude of Response With Myeloma Frontline Therapy Does Not Predict Outcome: Importance of Time to Progression in Southwest Oncology Group Chemotherapy TrialsJournal of Clinical Oncology, 2004
- Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapyBlood, 2002